Levacetylleucine
Levacetylleucine is an investigational medication being studied for the treatment of Niemann-Pick disease type C (NPC), a rare genetic disorder characterized by impaired cholesterol trafficking leading to progressive neurological decline. While the exact molecular target of levacetylleucine in NPC remains unknown, clinical studies have explored its potential to improve neurological symptoms in affected patients.
Levacetylleucine is an investigational treatment for Niemann-Pick disease type C, a rare lysosomal storage disorder affecting neurological function.
Key facts at a glance
- ATC
- N07XX27
- RxNorm
- 2375522
- Generic
- Levacetylleucine
- Class
- atc-n07
- Brands
- Aqneursa
- Availability
- rx
- Lactation
- unknown
- Routes
- oral
- Forms
- suspension
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Levacetylleucine is being investigated for the treatment of Niemann-Pick disease type C (NPC), a rare autosomal recessive lysosomal storage disorder caused by mutations in NPC1 or NPC2 genes that result in impaired intracellular cholesterol trafficking and progressive neurological deterioration.
The precise molecular mechanism by which levacetylleucine exerts its therapeutic effects in NPC is not yet fully understood. It is thought to potentially modulate cellular trafficking pathways and improve neuronal function, though the specific target remains unknown.
Levacetylleucine has received orphan drug designation from regulatory authorities for NPC treatment. It is currently under clinical investigation and not yet approved for routine clinical use. Patients should only access this medication through clinical trials or compassionate use programs under physician supervision.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy